Enzalutamide as a Radiosensitizer in Prostate Cancer Cell Lines

被引：0
|
作者：
Barrado, M. [1 ]
Escors, D. [2 ]
Arias, F. [1 ]
Blanco, I. [2 ]
Arteta, V. [2 ]
Visus, I. [1 ]
Campo, M. [1 ]
Flamarique, S. [1 ]
Navarrete, P. A. [1 ]
Martinez, E. [1 ]
机构：
[1] Complejo Hosp Navarra Pamplona, Pamplona, Spain
[2] Fdn Miguel Servet, Pamplona, Spain
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2510
引用
收藏
页码：E212 / E212
页数：1
相关论文
共 50 条
  • [1] Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines
    Soares, Silvia
    Faria, Isabel
    Aires, Fatima
    Monteiro, Armanda
    Pinto, Gabriela
    Sales, Maria Goreti
    Correa-Duarte, Miguel A.
    Guerreiro, Susana G.
    Fernandes, Ruben
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [2] Enzalutamide versus abiraterone as a radiosensitizer in hormone-sensitive prostate cancer cells
    Ghashghaei, Maryam
    Muanza, Thierry
    Alaoui-Jamali, Moulay
    Paliouras, Miltiadis
    Niazi, Mohammad Tamim
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
    Rebecca Smith
    Moqing Liu
    Tiera Liby
    Nora Bayani
    Elmar Bucher
    Kami Chiotti
    Daniel Derrick
    Anne Chauchereau
    Laura Heiser
    Joshi Alumkal
    Heidi Feiler
    Peter Carroll
    James E. Korkola
    Scientific Reports, 10
  • [4] Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
    Smith, Rebecca
    Liu, Moqing
    Liby, Tiera
    Bayani, Nora
    Bucher, Elmar
    Chiotti, Kami
    Derrick, Daniel
    Chauchereau, Anne
    Heiser, Laura
    Alumkal, Joshi
    Feiler, Heidi
    Carroll, Peter
    Korkola, James E.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [5] Enzalutamide in Prostate Cancer, A Review on Enzalutamide and cancer
    Erdogan, Bulent
    Kostek, Osman
    Bekirhacioglu, Muhammet
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2018, 2 (03): : 121 - 129
  • [6] Study of the response of ovarian cancer cell lines to enzalutamide
    Aiestaran-Llorente, Ibone
    Arroyo-Garrapucho, Nuria
    Martin-Bejarano Soto, Paloma
    Herrero, Ana-Belen
    Gonzalez-Sarmiento, Rogelio
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 561 - 561
  • [7] Enzalutamide for prostate cancer
    Tanday, Sanjay
    LANCET ONCOLOGY, 2012, 13 (10): : E413 - E413
  • [8] Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts
    Laird, James H.
    Lok, Benjamin H.
    Ma, Jennifer
    Bell, Andrew
    de Stanchina, Elisa
    Poirier, John T.
    Rudin, Charles M.
    CLINICAL CANCER RESEARCH, 2018, 24 (20) : 5143 - 5152
  • [9] Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
    Li, Yingming
    Chan, Siu Chiu
    Brand, Lucas J.
    Hwang, Tae Hyun
    Silverstein, Kevin A. T.
    Dehm, Scott M.
    CANCER RESEARCH, 2013, 73 (02) : 483 - 489
  • [10] Enzalutamide for the treatment of prostate cancer
    Pal, Sumanta K.
    Stein, Cy A.
    Sartor, Oliver
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (05) : 679 - 685
12345